← Leaderboards
Warren N Schmidt
University Of Iowa
$1,017,201
Attributed
$1,017,201
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $190.2K · FY2005–21$200K$150K$100K$50K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$1,017,201 · 4
VA$0 · 1
By mechanism
R01$516,796 · 1
R21$342,019 · 1
R03$147,000 · 1
M01$11,386 · 1
I01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Iowa
Same institution · by research overlap
- Harold M. Goff$347,026
- Paul B McCray$33,563,463
- David J Moser$3,890,597
- Aliye Uc$10,425,725
- Matthew Dannenberg$722,539
Others in their field
Top investigators on “Hepatitis C”
- Constance Ann Benson · University Of California, San Diego$171,085,251
- Sharon A Nachman · Johns Hopkins University$116,441,543
- Peter B. Gilbert · Fred Hutchinson Cancer Center$94,107,997
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$70,290,471
- Richard Douglas Moore · Johns Hopkins University$59,121,971
- Charles R Rinaldo · University Of Pittsburgh At Pittsburgh$46,122,050
Research focus
Hepatitis CHepatitis C VirusAntiviral AgentsLiver DiseasesIn VivoIn VitroChronic Hepatitis CVirusHepatocyteCirrhosisVeteransEnzymesAntiviral TherapyViralCellsInterferonsInterferon-AlphaIncidenceInjuryLife Cycle StagesLaboratoriesBiliverdineGenotypeBilirubin
Grant awards (21)
Neoplastic interactions of hepatitis C virus with telomerase.$0
I01 · FY2021 · VA · contact PI
Neoplastic interactions of hepatitis C virus with telomerase.$0
I01 · FY2020 · VA · contact PI
Neoplastic interactions of hepatitis C virus with telomerase.$0
I01 · FY2019 · VA · contact PI
Neoplastic interactions of hepatitis C virus with telomerase.$0
I01 · FY2018 · VA · contact PI
Anti HCV Protease Activities of Metalloporphyrins$0
I01 · FY2016 · VA · contact PI
Anti HCV Protease Activities of Metalloporphyrins$0
I01 · FY2015 · VA · contact PI
Anti HCV Protease Activities of Metalloporphyrins$0
I01 · FY2014 · VA · contact PI
Anti HCV Protease Activities of Metalloporphyrins$0
I01 · FY2013 · VA · contact PI
Heme Oxygenase-1 Inhibition of Hepatitis C Replication$0
I01 · FY2012 · VA · contact PI
Heme Oxygenase-1 Inhibition of Hepatitis C Replication$0
I01 · FY2011 · VA · contact PI
Heme Oxygenase-1 Inhibition of Hepatitis C Replication$0
I01 · FY2011 · VA · contact PI
Heme Oxygenase-1 Inhibition of Hepatitis C Replication$0
I01 · FY2009 · VA · contact PI
Heme Oxygenase-1 and Hepatitis C$153,799
R21 · FY2006 · DK · contact PI
Heme Oxygenase-1 and Hepatitis C$188,220
R21 · FY2005 · DK
THALIDOMIDE IN PATIENTS WITH ACUTE ALCOHOLIC HEPATITIS$1,942
M01 · FY2005 · RR
THALIDOMIDE IN PATIENTS WITH ACUTE ALCOHOLIC HEPATITIS$9,444
M01 · FY2004 · RR
ALCOHOL EFFECTS ON LIVER DISEASE IN HCV AND HIV COINFECT$172,563
R01 · FY2002 · AA
ALCOHOL EFFECTS ON LIVER DISEASE IN HCV AND HIV COINFECT$172,563
R01 · FY2001 · AA
QUANTITATION OF HEPATITIS C VIRUS IN PERIPHERAL BLOOD$73,500
R03 · FY2001 · DK
ALCOHOL EFFECTS ON LIVER DISEASE IN HCV AND HIV COINFECT$171,670
R01 · FY2000 · AA
QUANTITATION OF HEPATITIS C VIRUS IN PERIPHERAL BLOOD$73,500
R03 · FY2000 · DK